Loss of response and frequency of adverse events in patients with ulcerative colitis and Crohn’s disease when switching from the original infliximab to its biosimilars - PDF (俄文)
版权所有 © Consilium Medicum, 2021
![Creative Commons License](http://licensebuttons.net/l/by-nc-sa/4.0/88x31.png)
此作品已接受知识共享署名-非商业性使用-相同方式共享 4.0国际许可协议的许可。